Literature DB >> 16437636

Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis.

K M Lammers1, S Ouburg, S A Morré, J B A Crusius, P Gionchett, F Rizzello, C Morselli, E Caramelli, R Conte, G Poggioli, M Campieri, A S Peña.   

Abstract

AIM: To investigate the single nucleotide polymorphisms (SNPs) in genes involved in bacterial recognition and the susceptibility to pouchitis or pouchitis severity.
METHODS: Analyses of CD14 -260C>T, CARD15/NOD2 3020insC, Toll-like receptor (TLR)4 +896A>G, TLR9 -1237T>C, TLR9+2848G>A, and IRAKM + 22148G>A SNPs were performed in 157 ileal-pouch anal anastomosis (IPAA) patients (79 patients who did not develop pouchitis, 43 infrequent pouchitis patients, 35 chronic relapsing pouchitis patients) and 224 Italian Caucasian healthy controls.
RESULTS: No significant differences were found in SNP frequencies between controls and IPAA patients. However, a significant difference in carriership frequency of the TLR9-1237C allele was found between the infrequent pouchitis and chronic relapsing pouchitis groups [P = 0.028, oddos ratio (OR) = 3.2, 95%CI = 1.2-8.6]. This allele uniquely represented a 4-locus TLR9 haplotype comprising both studied TLR9 SNPs in Caucasians. Carrier trait analysis revealed an enhanced combined carriership of the alleles TLR9 -1237C and CD14 -260T in the chronic relapsing pouchitis and infrequent pouchitis group (P = 0.018, OR = 4.1, 95%CI = 1.4 -12.3).
CONCLUSION: There is no evidence that the SNPs predispose to the need for IPAA surgery. The significant increase of the combined carriership of the CD14 -260T and TLR9 -1237C alleles in the chronic relapsing pouchitis group suggests that these markers identify a subgroup of IPAA patients with a risk of developing chronic or refractory pouchitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16437636      PMCID: PMC4725145          DOI: 10.3748/wjg.v11.i46.7323

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  48 in total

1.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

Authors:  P Gionchetti; F Rizzello; A Venturi; P Brigidi; D Matteuzzi; G Bazzocchi; G Poggioli; M Miglioli; M Campieri
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

2.  A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E.

Authors:  M Baldini; I C Lohman; M Halonen; R P Erickson; P G Holt; F D Martinez
Journal:  Am J Respir Cell Mol Biol       Date:  1999-05       Impact factor: 6.914

3.  Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria.

Authors:  M Rescigno; M Urbano; B Valzasina; M Francolini; G Rotta; R Bonasio; F Granucci; J P Kraehenbuhl; P Ricciardi-Castagnoli
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

Review 4.  Toll receptors, CD14, and macrophage activation and deactivation by LPS.

Authors:  Marina A Dobrovolskaia; Stefanie N Vogel
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

5.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

6.  Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway.

Authors:  M G Cleveland; J D Gorham; T L Murphy; E Tuomanen; K M Murphy
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

7.  Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14.

Authors:  E Hailman; T Vasselon; M Kelley; L A Busse; M C Hu; H S Lichenstein; P A Detmers; S D Wright
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

8.  Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.

Authors:  Naohiro Inohara; Yasunori Ogura; Ana Fontalba; Olga Gutierrez; Fernando Pons; Javier Crespo; Koichi Fukase; Seiichi Inamura; Shoichi Kusumoto; Masahito Hashimoto; Simon J Foster; Anthony P Moran; Jose L Fernandez-Luna; Gabriel Nuñez
Journal:  J Biol Chem       Date:  2003-01-04       Impact factor: 5.157

9.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

10.  Human monocyte CD14 is upregulated by lipopolysaccharide.

Authors:  R Landmann; H P Knopf; S Link; S Sansano; R Schumann; W Zimmerli
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more
  20 in total

Review 1.  Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.

Authors:  Bo Shen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

2.  ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis.

Authors:  Jennifer A Coukos; Lauren A Howard; Janice M Weinberg; James M Becker; Arthur F Stucchi; Francis A Farraye
Journal:  Dig Dis Sci       Date:  2012-02-07       Impact factor: 3.199

3.  The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma.

Authors:  A Carvalho; C Cunha; A J Almeida; N S Osório; M Saraiva; M Teixeira-Coelho; S Pedreiro; E Torrado; N Domingues; A G Gomes-Alves; A Marques; J F Lacerda; M G da Silva; M Gomes; A C Pinto; F Torres; P Rendeiro; P Tavares; M Di Ianni; R Medeiros; P Heutink; P M Bracci; L Conde; P Ludovico; J Pedrosa; P Maciel; L Pitzurra; F Aversa; H Marques; A Paiva; C F Skibola; L Romani; A G Castro; F Rodrigues
Journal:  Genes Immun       Date:  2011-08-25       Impact factor: 2.676

Review 4.  Review article: the pathogenesis of pouchitis.

Authors:  K M Schieffer; E D Williams; G S Yochum; W A Koltun
Journal:  Aliment Pharmacol Ther       Date:  2016-08-24       Impact factor: 8.171

5.  Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients?

Authors:  Nielce M de Paiva; Maria L S Ayrizono; Marciane Milanski; Andressa Coope; Luiza M F Oliveira; João J Fagundes; Lício A Velloso; Cláudio S R Coy; Raquel F Leal
Journal:  Int J Clin Exp Med       Date:  2011-09-15

6.  Association between gene polymorphisms of IRAK-M and the susceptibility of sepsis.

Authors:  Gao-Hong Dong; Jian-Ping Gong; Jin-Zheng Li; Yu-Hong Luo; Zhen-Dong Li; Pei-Zhi Li; Kun He
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

Review 7.  Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects.

Authors:  István Fűri; Ferenc Sipos; Tiana M Germann; Alexandra Kalmár; Zsolt Tulassay; Béla Molnár; Györgyi Műzes
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

8.  Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis.

Authors:  Phillip Fleshner; Andrew Ippoliti; Marla Dubinsky; Eric Vasiliauskas; Ling Mei; Konstantinos A Papadakis; Jerome I Rotter; Carol Landers; Stephan Targan
Journal:  Clin Gastroenterol Hepatol       Date:  2008-04-18       Impact factor: 11.382

9.  TLR2, TLR4 and TLR9 genotypes and haplotypes in the susceptibility to and clinical course of Chlamydia trachomatis infections in Dutch women.

Authors:  Stephan P Verweij; Ouafae Karimi; Jolein Pleijster; Joseph M Lyons; Henry J C de Vries; Jolande A Land; Servaas A Morré; Sander Ouburg
Journal:  Pathog Dis       Date:  2015-11-13       Impact factor: 3.166

Review 10.  Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer.

Authors:  A Trejo-de la O; P Hernández-Sancén; C Maldonado-Bernal
Journal:  Genes Immun       Date:  2014-03-13       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.